Skip to content
Encoded Therapeutics
-
Encoded Therapeutics raises US$27M to advance Dravet syndrome gene therapy
Encoded plans to use the proceeds primarily to fund a pivotal trial of ETX101 in infants and young children with SCN1A positive Dravet syndrome.